• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

静脉血栓栓塞中的纤维蛋白溶解。

Fibrinolysis in Venous Thromboembolism.

机构信息

Institute of Cardiology, Jagiellonian University Medical College, Krakow, Poland.

Krakow Centre for Medical Research and Technologies, John Paul II Hospital, Krakow, Poland.

出版信息

Semin Thromb Hemost. 2021 Jul;47(5):480-489. doi: 10.1055/s-0041-1725094. Epub 2021 Apr 20.

DOI:10.1055/s-0041-1725094
PMID:33878786
Abstract

Fibrinolysis is of paramount importance in maintaining or regaining the patency of veins and pulmonary arteries obstructed by thrombi. Growing experimental and clinical evidence indicates that impaired fibrinolysis mediated by multiple complex mechanisms is involved in venous thromboembolism (VTE). Global plasma fibrin clot lysis markers, especially clot lysis time, have been reported to predict recurrent deep-vein thrombosis and pulmonary embolism. The current overview summarizes available data linking fibrinolysis to VTE and its long-term sequelae.

摘要

纤维蛋白溶解在维持或恢复被血栓阻塞的静脉和肺动脉的通畅方面至关重要。越来越多的实验和临床证据表明,多种复杂机制介导的纤溶受损与静脉血栓栓塞症(VTE)有关。已报道全球血浆纤维蛋白凝块溶解标志物,尤其是凝块溶解时间,可预测复发性深静脉血栓形成和肺栓塞。本综述总结了将纤溶与 VTE 及其长期后果联系起来的现有数据。

相似文献

1
Fibrinolysis in Venous Thromboembolism.静脉血栓栓塞中的纤维蛋白溶解。
Semin Thromb Hemost. 2021 Jul;47(5):480-489. doi: 10.1055/s-0041-1725094. Epub 2021 Apr 20.
2
Improving fibrinolysis in venous thromboembolism: impact of fibrin structure.改善静脉血栓栓塞症中的纤维蛋白溶解:纤维蛋白结构的影响。
Expert Rev Hematol. 2019 Aug;12(8):597-607. doi: 10.1080/17474086.2019.1627193. Epub 2019 Jul 5.
3
Plasma Fibrin Clot Properties Are Unfavorably Altered in Women following Venous Thromboembolism Associated with Combined Hormonal Contraception.静脉血栓栓塞症合并联合激素避孕的女性,其血浆纤维蛋白凝块特性发生不利改变。
Dis Markers. 2019 Nov 18;2019:4923535. doi: 10.1155/2019/4923535. eCollection 2019.
4
Prothrombotic fibrin clot properties are associated with post-discharge venous thromboembolism in acutely ill medical patients.急性病医学患者出院后的静脉血栓栓塞与促血栓形成纤维蛋白凝块特性相关。
Thromb Res. 2019 Oct;182:141-149. doi: 10.1016/j.thromres.2019.08.010. Epub 2019 Aug 19.
5
Plasma fibrin clot properties in the G20210A prothrombin mutation carriers following venous thromboembolism: the effect of rivaroxaban.静脉血栓栓塞症后 G20210A 凝血酶原突变携带者的血浆纤维蛋白凝块特性:利伐沙班的影响。
Thromb Haemost. 2017 Aug 30;117(9):1739-1749. doi: 10.1160/TH17-01-0060. Epub 2017 Aug 3.
6
Altered fibrin clot structure/function in patients with idiopathic venous thromboembolism and in their relatives.特发性静脉血栓栓塞症患者及其亲属的纤维蛋白凝块结构/功能改变。
Blood. 2009 Nov 5;114(19):4272-8. doi: 10.1182/blood-2009-05-222380. Epub 2009 Aug 18.
7
Endogenous fibrinolysis-Relevance to clinical thrombosis risk assessment.内源性纤溶-与临床血栓风险评估的相关性。
Eur J Clin Invest. 2021 Apr;51(4):e13471. doi: 10.1111/eci.13471. Epub 2020 Dec 16.
8
Prothrombotic Fibrin Clot Phenotype in Patients with Deep Vein Thrombosis and Pulmonary Embolism: A New Risk Factor for Recurrence.深静脉血栓形成和肺栓塞患者的促血栓形成纤维蛋白凝块表型:复发的新危险因素。
Biomed Res Int. 2017;2017:8196256. doi: 10.1155/2017/8196256. Epub 2017 Jun 27.
9
Altered Plasma Clot Properties and Trauma-Related Venous Thromboembolism despite Thromboprophylaxis.尽管进行了血栓预防,但血浆凝块特性改变与创伤相关的静脉血栓栓塞症。
Thromb Haemost. 2018 Apr;118(4):654-663. doi: 10.1055/s-0038-1636535. Epub 2018 Apr 4.
10
Factor XIII and Fibrin Clot Properties in Acute Venous Thromboembolism.急性静脉血栓栓塞症中的因子 XIII 和纤维蛋白凝块特性。
Int J Mol Sci. 2021 Feb 5;22(4):1607. doi: 10.3390/ijms22041607.

引用本文的文献

1
Potential association of TGFβ1 plasma levels and fibrinolysis parameters with the risk of recurrence and vascular obstruction after a first unprovoked pulmonary embolism episode.首次无诱因肺栓塞发作后,血浆转化生长因子β1水平及纤溶参数与复发风险和血管阻塞的潜在关联。
J Thromb Thrombolysis. 2025 Jun 22. doi: 10.1007/s11239-025-03113-2.
2
Targeting Fibrinolytic Inhibition for Venous Thromboembolism Treatment: Overview of an Emerging Therapeutic Approach.靶向纤维蛋白溶解抑制治疗静脉血栓栓塞症:一种新兴治疗方法概述。
Circulation. 2024 Sep 10;150(11):884-898. doi: 10.1161/CIRCULATIONAHA.124.069728. Epub 2024 Sep 9.
3
Overall haemostatic potential assay for prediction of outcomes in venous and arterial thrombosis and thrombo-inflammatory diseases.
整体止血潜能检测在静脉和动脉血栓形成及血栓炎症性疾病中的预后预测作用。
J Thromb Thrombolysis. 2024 Jun;57(5):852-864. doi: 10.1007/s11239-024-02975-2. Epub 2024 Apr 22.
4
The Fibrinolytic System and Its Measurement: History, Current Uses and Future Directions for Diagnosis and Treatment.纤维蛋白溶解系统及其检测:用于诊断和治疗的历史、当前用途和未来方向。
Int J Mol Sci. 2023 Sep 16;24(18):14179. doi: 10.3390/ijms241814179.
5
Impaired fibrinolysis and increased clot strength are potential risk factors for thrombosis in lymphoma.纤维蛋白溶解受损和血栓强度增加是淋巴瘤患者发生血栓的潜在危险因素。
Blood Adv. 2023 Nov 28;7(22):7056-7066. doi: 10.1182/bloodadvances.2023011379.
6
The role of fibrinolysis in vascular diseases in UK biobank.纤维蛋白溶解在英国生物银行血管疾病中的作用。
J Thromb Thrombolysis. 2023 Nov;56(4):635-638. doi: 10.1007/s11239-023-02876-w. Epub 2023 Aug 11.
7
Modified Rotational Thromboelastometry Protocol Using Tissue Plasminogen Activator for Detection of Hypofibrinolysis and Hyperfibrinolysis.改良旋转血栓弹性描记术方案联合组织型纤溶酶原激活剂用于检测低纤维蛋白溶解和高纤维蛋白溶解。
Methods Mol Biol. 2023;2663:763-773. doi: 10.1007/978-1-0716-3175-1_51.
8
Effects of clot contraction on clot degradation: A mathematical and experimental approach.凝块收缩对凝块降解的影响:一种数学和实验方法。
Biophys J. 2022 Sep 6;121(17):3271-3285. doi: 10.1016/j.bpj.2022.07.023. Epub 2022 Aug 3.